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a  b  s  t  r  a  c  t
Ageing  is a process  that gradually  increases  the  organism’s  vulnerability  to death.  It affects  different  bio-
logical  pathways,  and  the underlying  cellular  mechanisms  are  complex.  In  view  of  the growing  disease
burden  of  ageing  populations,  increasing  efforts  are being  invested  in understanding  the  pathways  and
mechanisms  of ageing.  We  review  some  mouse  models  commonly  used  in  studies  on ageing,  highlight
the  advantages  and  disadvantages  of  the  different  strategies,  and  discuss  their  relevance  to disease  sus-eywords:
geing
ouse models
elayed ageing
ceptibility.  In addition  to addressing  the  genetics  and  phenotypic  analysis  of  mice, we  discuss  examples
of  models  of  delayed  or accelerated  ageing  and their  modulation  by caloric  restriction.
©  2016  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).ccelerated ageing
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. Introduction
The simplest and best model of ageing is an old organism. This
pproach has been successful when using lower organisms such
s C. elegans and Drosophila, but studies on mice are hampered
y cost and time. However, what makes the mouse an attractive
odel for studying mammalian biology is the genetic manage-
bility of its genome, ease of breeding, and the large amount of
vailable baseline phenotypic data. Similarities and differences
etween mouse and man  in relation to studies on ageing have
een reviewed (Vanhooren and Libert, 2013). Here, we  examine
ome recent mouse studies on ageing to highlight the advantages
nd disadvantages of various strategies, with a particular emphasis
n genetics and phenotypic analysis. We  also discuss examples of
odulating ageing in mice genetically or by caloric restriction (CR).
. Importance and usefulness of genetic background
Inbred mice are widely used in research. The advantages of these
trains are deﬁned genomes, stable phenotypes, and extensive data
hat are freely available from published studies and from databases
uch as mouse genome informatics (MGI) and mouse phenome
atabase (MPD) (Eppig et al., 2015; Bogue et al., 2016). However,
hough the phenotypes have often been characterized in detail,
henotypes resulting from speciﬁc allelic variants in inbred strains
an often be overlooked. As we examine the mammalian genome in
ore detail with ever increasing detailed phenotyping, we will no
oubt discover other important variants. The most commonly used
nbred strain is probably C57BL/6J, which carries several known
llelic variants that could inﬂuence phenotypic outcomes of manip-
lations or treatments. Notably, an allelic variant of the Cdh23
utation delays the onset of hearing loss (Henry and Chole, 1980;
ohnson et al., 2006). As hearing loss affects various behaviors, this
train is unsuitable for mutational studies on age-related hearing
oss. More importantly, C57BL/6J mice carry a deletion in nicoti-
amide nucleotide transhydrogenase (Nnt) (Toye et al., 2005) that
mpairs glucose tolerance (Freeman et al., 2006). This is particularly
mportant because of the close relationship between metabolism
nd ageing (Newgard and Pessin, 2014). Other strain-speciﬁc dif-
erences are in bone mineral density (Beamer et al., 1996), tumor
usceptibility, and atherosclerosis (Paigen et al., 1987a, 1987b), all
f which are relevant to age-related disease. Such allelic variation
an result in phenotypic differences even between closely related
trains (Simon et al., 2013; Vanden Berghe et al., 2015). The varia-
ion between inbred strains is not restricted to primary phenotypic
ifferences but can inﬂuence the response to interventions. The
esponse to CR is clearly strain speciﬁc (Liao et al., 2010a), demon-
trating the inﬂuence of genetic background on the outcomes of
uch studies. Elucidation of this phenomenon may  enhance our
nderstanding of how dietary restriction pathways regulate age-
ng.
Strain-speciﬁc differences and the need for models that reﬂect
he genetic diversity of human populations has led to the
evelopment of strategies to generate genetically diverse mouse
opulations. These strategies include recombinant inbred (RI) mice
Williams et al., 2004), collaborative cross (CC) mice (Churchill et al.,
004), and now the diversity outbred (DO) (Churchill et al., 2012;
venson et al., 2012) strains derived from CC mice. The CC lines
re multiple inbred lines with a wide genetic diversity, thus negat-
ng the need for mapping, but each DO mouse is genetically unique.
nbred Long Sleep (ILS) ILSXISS RI strains have been used to demon-
trate that the effect of dietary restriction (DR) is under genetic
ontrol (Liao et al., 2010a); lifespan was extended in some strains
ut shortened in others. These strains can be used to study the
enetic basis of complex traits, but such studies rely on exten- Development 160 (2016) 41–53
sive genetic variation already present in the founder strains. While
the introduction of genetic variations to study speciﬁc pathways
or allelic variants provides a better model of the genetic diver-
sity in humans, it can present logistical problems. The advent of
CRISPR technologies (Wang et al., 2013) has made it possible to
introduce mutations in the CC strains, but this would involve mak-
ing mutations in multiple strains, which is possible but expensive.
For mixed strains, such as the UM-HET3 derived from four strains
used in the Intervention Testing Program (ITP) (Nadon et al., 2008;
Miller and Chrisp, 1999), a mutation can be introduced into one of
the strains, followed by normal breeding. However, this will ﬁx the
region around the mutation to that of a single founder strain and
reduce the overall genetic variation. Furthermore, introduction of
recessive variants requires the introduction of the genetic variant
in more than one strain or a more extensive breeding protocol. This
is possible but more expensive in terms of breeding. Depending on
how breeding is managed, even outbred mouse colonies can suffer
from reduced genetic variance (Yalcin et al., 2010).
Combining genomes randomly can generate unexpected results,
as exempliﬁed by the study of Bygraves et al. These authors demon-
strated that sequence variants between 129 and C57BL/6J mice
in a chromosomal region linked to the development of systemic
lupus erythematosus (SLE) resulted in disease on a mixed genetic
background but not in the inbred strains, thus confounding the
phenotypic interpretation of various knock out lines generated
in this region because of the retention of ﬂanking DNA (Bygrave
et al., 2004). The importance of sequence variants is further sup-
ported by the substantial inﬂuence of passenger mutations in
congenic mice on interpreting phenotypic data (Vanden Berghe
et al., 2015). Thus, while a mixed background may  be a more
relevant model of the outbred human population, complications
could arise. The inﬂuence of such variations can be examined by
sufﬁciently powered experimental design (Miller et al., 2007). In
particular, inter-strain differences should be taken into consider-
ation when introducing a mutation and thereby ﬁxing a region
of the genome in that population of mice. Modiﬁers of pheno-
types are useful in revealing genetic control of phenotypes by QTL
studies. In ageing studies, genetic modiﬁers have proved useful in
demonstrating the genetic control of phenotypes associated with
immune ageing (Jackson et al., 1999) and with lifespan (Jackson
et al., 2002).
In addition to considering the range of strains available, the phe-
notyping process should also be considered. There is an increasing
number of phenotypic tests that can be used in mice to study the
effects of perturbations such as ageing on physiological systems.
The use of more detailed phenotyping of parameters reﬂecting
health status has shifted the emphasis from lifespan to health-span.
A large-scale analysis of ageing in 31 inbred strains was  undertaken
at the Jackson Laboratories as part of the Ageing Phenome Project.
The study provided an insight into the phenotypic variation that
occurs in these strains as they age (Yuan et al., 2009). Cohorts of 32
male and 32 female mice were examined in a longitudinal study
and phenotyped at different times throughout their life. Pheno-
typing of the cohorts included lifespan, hormone levels (including
insulin-like growth factor 1; IGF-1), clinical chemistry, peripheral
blood leucocyte populations, electrophysiology, and hematologi-
cal, metabolic and sleep analysis. This study demonstrated a link
of IGF-1 levels with longevity, as well as with several other impor-
tant age-related conditions, such as changes in renal function (Tsaih
et al., 2010), immune cell populations (Petkova et al., 2008), gait
(Wooley et al., 2009), and cardiac function (Xing et al., 2009). Such
analyses yield important reference data (Bogue et al., 2016) for
researchers and help to build a picture of ageing and disease in
these strains. These analyses also make it possible to identify the
optimum age for studying a particular strain. Nevertheless, further
ng and
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n depth phenotypic analysis is needed to understand the ageing of
nbred strains.
Phenotypic data are being increasingly incorporated into ageing
tudies. However, there is no agreement on the range of phenotypic
ests, study time points and other parameters. Standard operat-
ng procedures (SOPs) have been employed successfully in large
cale phenotyping programs (Ayadi et al., 2012; de Angelis et al.,
015; White et al., 2013; Brown and Moore, 2012; Brown et al.,
006, 2005). SOPs are needed to reduce inter-laboratory variations,
uch as the differences in the reported effects of CR in primates
Mattison et al., 2012; Colman et al., 2014). The ITP uses standard-
zed protocols at three sites (Nadon et al., 2008) to unify the diet and
nvironment in order to ensure reproducibility. However, despite
trict SOPs and efforts to reduce variability, differences between
ites have been identiﬁed; most probably due to environmental
ifferences. There was a difference in survival of males across the
hree sites of the ITP (Nadon et al., 2008), and the EUMODIC program
dentiﬁed site-speciﬁc differences in some phenotypic parameters.
his highlights the difﬁculty of developing robust protocols, which
ay  have to include even metadata such as diet and age of the
ice used for breeding because these factors might have long term
ffects on the offspring (Martin-Gronert and Ozanne, 2013).
Detailed phenotyping is now being employed in studies on
geing to investigate comorbidities associated with ageing and to
nvestigate longevity. Additionally, emerging, deﬁned phenotyp-
ng pipelines (Ackert-Bicknell et al., 2015) take into consideration
he differences between longitudinal and cross sectional designs
nd the effect of previous tests, which are particularly important in
ehavioral testing. The importance of comprehensive phenotyping
s underlined by the known side effect of rapamycin treatment (tes-
icular degeneration), which may  hint at other unknown effects.
etailed phenotypic analysis will also help elucidate the effects
f rapamycin treatment and dietary restriction, both of which
engthen lifespan and health-span but have different effects on
etabolism (Miller et al., 2014).
Neff et al. demonstrated the value of using a wide range of
henotyping, and in particular phenotyping over the lifespan of
 mouse. They found that rapamycin treatment had early effects
n cognitive function but little effect on many ageing pheno-
ypes, and that lifespan extension was primarily due to reduction
f tumor burden. This led to the conclusion that rapamycin has
imited effects on ageing. This interpretation has been challenged
Blagosklonny, 2013). Nevertheless, this study does demonstrate
he importance of detailed phenotyping throughout the life of a
ouse.
Data from studies on DO strains demonstrate that complex, time
onsuming phenotypic tests that are highly relevant to human
geing can be fruitful; they show that preservation of neuronal
tructures in old mice is correlated with better memory (Koh et al.,
014).
. Mouse models of ageing
Ageing research on mice is expensive and time-consuming.
herefore, it is tempting to study ageing using mice with accel-
rated ageing and/or reduced lifespan (Table 1). However, these
tudies should be interpreted with care. Those mice might show
ypical features of ageing, but they often exhibit features not seen
n normal old mice. A parallel to this is seen in patients with
utchinson-Gilford progeria syndrome, a genetic condition charac-
erized by the rapid appearance of ageing beginning in childhood.
lthough these patients display some characteristics of normal
geing, they also present many characteristics not seen among
he elderly. Consequently, all available mouse models of acceler-
ted ageing do not fully represent normal ageing in mice (Miller, Development 160 (2016) 41–53 43
2004). Nevertheless, mouse models of accelerated ageing can pro-
vide insight into the mechanisms of deterioration seen in normal
physiological ageing and into the premature ageing process in
progeroid syndromes, as long as these differences are kept in mind
(Vanhooren and Libert, 2013). Research on mice with delayed age-
ing might also provide insight into how ageing rate is controlled.
This could be a ﬁrst step towards development of drugs to slow
ageing and subsequently to delay disease progression (Miller et al.,
2011).
3.1. Progeroid syndromes
Progeroid syndromes are extremely rare human diseases char-
acterized by premature ageing and shortened lifespan. Progeroid
syndromes include laminopathies (such as the Hutchinson-Gilford
progeria syndrome; HGPS), which affect nuclear envelope homeo-
stasis, and diseases affecting DNA repair mechanisms and telomere
length, such as Cockayne syndrome, Werner syndrome (WS), ataxia
telangiectasia, and trichothiodystrophy (Liao and Kennedy, 2014).
These conditions exhibit many features of human normal age-
ing physiology, and identiﬁcation of the mutations causing them
has allowed the generation of mouse models of premature age-
ing. HGPS and WS  are the best characterized progeria mouse
models. Wolfram syndrome (WFS) is a very rare genetic disor-
der caused by mutations in the WFS1 gene and characterized by
diabetes insipidus, diabetes mellitus, optic atrophy and deafness
(DIDMOAD) (Wolfram and Wagener, 1938; Collier et al., 1996).
Lifespan is reduced in WFS  and average life expectancy is 30 years.
Although the speciﬁc function of WFS1 is not known, Wolframin,
the transmembrane protein encoded by the WFS1 gene, is thought
to be involved in regulation of endoplasmic reticulum (ER) stress
and calcium homeostasis.
3.1.1. Mouse models of Hutchinson-Gilford progeria syndrome
HGPS begins within the ﬁrst two years of life and average
life expectancy is 13.5 years. Patients display growth retarda-
tion, lipodystrophy, scleroderma, bone abnormalities (such as
joint stiffening and impaired mobility due to osteodysplasia with
osteolysis), alopecia, and midface hypoplasia. Cardiovascular com-
plications, such as myocardial infarction or stroke due to premature
atherosclerosis, are the most frequent cause of death. HGPS is
a progeroid laminopathy caused mainly by de novo point muta-
tions in the nuclear lamina A (LAMNA) (De Sandre-Giovannoli
et al., 2003; Eriksson et al., 2003). The gene encodes A-type lamins
(lamin A/C), which form the nuclear envelope. Mutations alter
the nuclear morphology and function, cause genomic instability,
and provoke aberrant cell proliferation. The most frequent HGPS
mutation is a deletion in the C-terminal domain that eliminates
a farnesylated proteolytic cleavage site for the zinc metallopro-
teinase ZMPSTE24. The result is an accumulation of a farnesylated
aberrant protein called progerin, which also occurs during normal
ageing.
Mouse models of HGPS are models of laminopathies based on
modiﬁcation of the Lamna gene or its processing enzyme (Zhang
et al., 2013a). LmnaHG knock-in mice (Yang et al., 2005, 2008)
express only progerin (the farnesylated uncleaved form of lamin
A), the accumulation of which leads to alteration of the nuclear
envelope. These mice lose subcutaneous fat and hair, develop
osteoporosis, and die prematurely without cardiovascular condi-
tions. LmnaG609G mice (mutation in 1827C > T; Gly609Gly) also
accumulate progerin due to defective splicing of the gene and
develop abnormal nuclear morphology (Osorio et al., 2011). At
three weeks of age, they exhibit growth retardation, reduced
weight gain, curvature of the spine and vascular calciﬁcation (Villa-
Bellosta et al., 2013), and they die at about 3.5 months (Osorio
et al., 2011). They also develop hypoglycemia and decreased level
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Table 1
Mouse models of accelerated ageing.
Mouse model Gene defect Physiologic alterationsa Age of disease
onset
Human
diseaseb
Relevant Referencesc
LmnaHG
knock-in mice
Farnesylated uncleaved
form of LMNA
Loss of subcutaneous fat, hair loss and
osteoporosis
6–8 weeks HGPS (Yang et al., 2005,
2008)
LmnaG609G
knock-in mice
Mutation in Lmna gene
(1827C > T)
Growth retardation, curvature in the
spine, vascular calciﬁcation, infertility,
decreased insulin-like growth factor
levels
3 weeks HGPS (Osorio et al., 2011;
Villa-Bellosta et al.,
2013)
Zmpste24−/− Deﬁciency in
metallopeptidase
Zmpste24 gene
Growth retardation, alopecia, muscle
weakness, bone fractures, dilated
cardiomyopathy, muscular dystrophy
and lipodistrophy
6–8 weeks HGPS (Bergo et al., 2002;
Pendas et al., 2002)
Wrn−/− WRN  protein
deﬁciency
Hypertriglyceridemia, insulin
resistance, elevated levels ROS, DNA
damage and increased incidence of
cancer
5 months WS (Lebel and Leder, 1998;
Massip et al., 2006)
Wrn−/− Terc−/− Double deﬁciency in
Wrn  and Terc genes
Shortening of telomeres, hair graying,
alopecia, osteoporosis, type 2 diabetes,
cataracts and cancer
late-generation
mice
WS (Chang et al., 2004)
Wfs1−/− Wfs1 gene deﬁciency Growth retardation, reduced number
of  pancreatic islets, diabetes, decreased
fertility
16 weeks WFS  (Koks et al., 2009;
Noormets et al., 2009;
Ishihara et al., 2004)
-cell  speciﬁc
Wfs1−/−
ˇ-cell speciﬁc Wfs1
gene deﬁciency
Reduced body weight and low insulin
levels diabetes
12 weeks WFS  (Riggs et al., 2005)
Wfs1−/− Wfs1-LacZ fusion gene Psychiatric symptoms, diabetes and
growth retardation
3–4 months WFS  (Noormets et al., 2011;
Luuk et al., 2009)
Cisd2−/− Cisd2 deﬁciency Early-onset degeneration of central
and peripheral nerves, opaque eyes
and blindness, decrease in bone
density, muscle atrophy, mitochondrial
degeneration, impaired glucose
tolerance and premature death
8 weeks WFS2 (Chen et al., 2009)
PolG  Mutation in mtDNA Pol
 gene
Kyphosis, alopecia, anemia, weight
loss, reduction in median lifespan,
sarcopenia, hearing loss, reduced fat
mass and bone mineral density,
cardiomyopathy.
Onset strain
dependent
Early ageing
phenotype
(Trifunovic et al., 2004;
Kujoth et al., 2005)
PolgAmut/mut Mutations in mtDNA
PolgA
Reduced lifespan and premature onset
of ageing-related phenotypes such as
weight loss, reduced subcutaneous fat,
alopecia, kyphosis, osteoporosis,
anemia, reduced fertility and heart
enlargement
∼25 weeks Early ageing
phenotype
(Trifunovic et al., 2004)
Nfkb1−/− mice Nfkb1deﬁciency Decrease in lifespan, premature
age-related skeletal changes, increased
tissue inﬂammation and central
nervous system gliosis, reduced
apoptosis and increased cellular
senescence
Middle-aged
mice
Early ageing
phenotype
(Bernal et al., 2014)
IL-10tm/tm IL-10 deﬁciency Anemic, extensive enterocolitis,
growth retarded, increased lethality,
iron depletion, faster muscle strength
decline
3–4 weeks Human frailty
syndrome
(Kuhn et al., 1993;
Walston et al., 2008)
Klotho−/− Klotho gene deﬁciency Infertility, arteriosclerosis, skin
atrophy, osteoporosis and emphysema
4 weeks Early ageing
phenotype
(Kuro-o et al., 1997)
XPD  Mutations in the DNA
helicase Xpd gene
Osteoporosis, osteosclerosis, early
graying, cachexia and infertility
3 months Trichothiodystrophy (de Boer et al., 2002)
ERCC1−/−or/− Mutation and/or
deletion in the Ercc1
gene.
Growth and liver failure, nuclear
anomalies, increased mortality, spleen
hypoplasia, altered isotype switching,
B cell hypoproliferation, dystonia,
ataxia, renal failure, sarcopenia,
kyphosis, early replicative ageing,
increased sensitivity to oxidative
stress, poor coordination, loss of visual
acuity, uraemic encephalopathy and
proteinuria
4 weeks Premature
ageing
phenotype
(Weeda et al., 1997;
Lawrence et al., 2008)
Terc−/− Terc deﬁciency Shortened lifespan, overall frailty,
decreased fertility and tissue atrophy
with impaired organ function
Late-
generation
Premature
ageing
phenotype
(Lee et al., 1998)
(HGPS, Hutchinson-Gilford progeria syndrome; ERCC1, excision repair cross complementing 1; IL-10, interleukin-10; Lmna, Lamin A; PolG, Polymerase ; Terc, Telomerase
RNA  component; Wfs, Wolfram syndrome; Wrn, Werner syndrome ATP-dependent helicase; WS,  Werner syndrome; XPD, xeroderma pigmentosum, complementation group
F;  Zmpste24, zinc metalloproteinase Ste24).
a Observed physiological alterations.
b Corresponding human condition.
c Relevant references listed.
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f insulin-like growth factor. Two independently generated mouse
odels deﬁcient in the Zmpste24 gene (Zmpste24−/− mice) showed
ccumulation of the farnesylated prelamin A protein (Bergo et al.,
002; Pendas et al., 2002). Although lack of the ZMPSTE24 gene in
umans causes perinatal death, Zmpste24−/− mice were viable and
isplayed a phenotype similar to that of HGPS patients. One of the
mpste24−/− mouse models developed growth retardation, alope-
ia, muscle weakness and bone fractures (Bergo et al., 2002) while
he other displayed dilated cardiomyopathy, muscular dystrophy
nd lipodystrophy, and died prematurely (Pendas et al., 2002).
.1.2. Mouse models of Werner syndrome
WS,  also known as ‘progeria of the adult,’ is manifested during
dolescence (10–20 years) and with an average median lifespan
f 54 years (Cox and Faragher, 2007). WS  patients have cataract,
rowth retardation, early graying, hair loss, scleroderma-like skin
hanges, osteoporosis, diabetes, atherosclerosis and high incidence
f cancer (Burtner and Kennedy, 2010). The condition is caused by
utations in Werner syndrome ATP-dependent helicase (WRN),
n enzyme with helicase and exonuclease activity involved in DNA
etabolism and in telomere homeostasis. The gene defect produces
enomic instability, including impaired DNA damage repair and
berrant proliferation (Burtner and Kennedy, 2010).
Several mouse models of WS  have been generated (Liao and
ennedy, 2014). Mice deﬁcient in the helicase unit of WRN  (Wrn−/−
ice) display hypertriglyceridemia, insulin resistance, elevated
evels of reactive oxygen species (ROS), oxidative DNA damage,
ncreased incidence of cancer, and a shortened lifespan (Lebel and
eder, 1998; Massip et al., 2006). Although Wrn−/− mice display
olecular and cellular alterations similar to those in WS  patients,
hey do not develop symptoms of accelerated ageing (Lombard
t al., 2000). However, double-mutant mice lacking both Wrn  and
elomerase RNA component (also known as Terc) genes reca-
itulate the progeroid symptoms closely related to WS (Chang
t al., 2004). These mice exhibit shortening of telomeres, prema-
ure death, hair graying, alopecia, osteoporosis, type II diabetes,
ataracts, increased chromosomal instability and cancer. These
tudies indicate that telomere attrition is a key factor in the
anifestation of WS  deﬁciencies. Similarly, Wrn−/− p53−/− double-
eﬁcient mice have a higher mortality rate than Wrn+/− p53−/−
ice, possibly due to increased genome instability or to accelera-
ion of the cancer phenotype by WRN  deﬁciency (Lombard et al.,
000).
.1.3. Mouse models of Wolfram syndrome
The function of the WFS1 gene is still unknown, but there is evi-
ence for its involvement in cell survival and degeneration (Koks
t al., 2009). A mouse model with WFS1 deﬁciency has shown
hat a non-functional Wfs1 gene causes growth retardation and
hortens life expectancy (Koks et al., 2009). Moreover, these mice
isplay activation of degenerative biological processes, resulting
n a reduced number of pancreatic islets, body weight and fertil-
ty (Noormets et al., 2009). WFS1-deﬁcient mice have permanently
ctivated ER stress, which leads to degeneration of several tissues.
Three different groups have developed WFS1-deﬁcient mice.
he ﬁrst WFS1 mutant mouse was developed by inserting a
eomycin (Neo) resistance cassette into exon 2 of the Wfs1 gene,
esulting in altered splicing of transcripts in the brain, heart and
slets (Ishihara et al., 2004). The authors speculate that the Neo
nsertion generates amino-terminus truncated WFS1 protein due
o translation from one of the internal start codons. At least three
ranscripts are annotated in the Ensembl database. Therefore, this
ind of Neo cassette knock-in might cause truncation of the WFS1
rotein without disturbing the reading frame. The non-fasted blood
lucose levels in these WFS1 mutant mice started to rise at the
ge of about 16 weeks, and by 36 weeks of age more than half Development 160 (2016) 41–53 45
of the mice had overt diabetes (Ishihara et al., 2004). Interest-
ingly, this effect was dependent on the genetic background of
mice, and diabetes was  not observed in the C57BL/6J background.
Again, this emphasizes the inﬂuence of the genetic background
on the phenotype. In addition, signiﬁcantly reduced insulin secre-
tion and increased apoptosis were found in these mice. Decreased
insulin secretion was caused by impaired coupling of stimulus to
secretion in WFS1-deﬁcient -cells. Interestingly, the authors did
not see reduced weight gain, blindness or any other features of
WFS.
Another WFS1 mutant mouse was made by using conditional
gene targeting to target WFS1 speciﬁcally in pancreatic islets. Exon
8 of the Wfs1 gene was  ﬂoxed and mutant mice were crossed
with rat insulin promoter (RIP-) Cre mice, resulting in deletion
of exon 8 in the Wfs1 gene speciﬁcally in -cells (Riggs et al.,
2005). As expected, these mice had pronounced diabetes, low blood
insulin levels, and impaired glucose tolerance. Interestingly, while
the WFS1 deﬁciency was islet-speciﬁc, these mice exhibited lower
body weight starting from the age of 24 weeks. This difference in
body weight was small but clearly signiﬁcant. In addition, studies
on these mice veriﬁed that WFS1 deﬁciency causes apoptosis and
increases the unfolded protein response (UPR) (Riggs et al., 2005).
Finally, the third available mouse model for WFS  was  devel-
oped using a more conventional approach and deleting exon 8
almost entirely (Koks et al., 2009), resulting in generation of a
small N-terminal part of WFS  fused to LacZ (Koks et al., 2009). This
strategy was chosen to obtain a model with maximal similarity to
WFS. Indeed, these WFS1-deﬁcient mice display a severe pheno-
typic abnormality that resembles WFS  in all the features studied
so far. The most signiﬁcant ﬁnding is that these mice stop grow-
ing at eight weeks of age and that they are 30% smaller than wild
type littermates (Koks et al., 2009). Despite being small, the growth
hormone (GH) pathway is activated in these mice and they have
increased IGF-1 levels (Koks et al., 2009). Diabetes is caused by
gradual degeneration of pancreatic islets and develops progres-
sively (Noormets et al., 2011). Moreover, fertility is reduced in
WFS1-deﬁcient mice (Noormets et al., 2009), which has also been
observed in WFS  patients. Finally, psychiatric symptoms are char-
acteristic in WFS  patients, and WFS1-deﬁcient mice also display
changes in the physiology of emotions and behavioral adaptation
(Luuk et al., 2009).
CDGSH iron sulfur domain (CISD2) gene has been identiﬁed as
a second causative gene associated with Wolfram syndrome (Amr
et al., 2007) and Cisd2 deﬁciency causes mitochondria-mediated
phenotypic defects in mice (Chen et al., 2009). Cisd2−/− mice
exhibit many clinical manifestations of WFS  patients including
early-onset degeneration of central and peripheral nerves and pre-
mature death, as well as impaired glucose tolerance (Chen et al.,
2009).
Collectively, these ﬁndings show that the different mouse mod-
els of WS  are good models for studying age-related processes and
degeneration.
3.2. Mitochondrial mutations and ageing
There is a correlation between age and the accumulation of
mitochondrial mutations and attenuation of mitochondrial func-
tion (Kennedy et al., 2013; Kazachkova et al., 2013). Hence, it has
been postulated that there may  also be a causative link between
the changes in mitochondria and the development of age-related
disease (Lee and Wei, 2012; Sun et al., 2016). As with nuclear
DNA there are speciﬁc mechanisms to maintain the integrity of the
mitochondrial genome during replication. There is a single DNA
polymerase in eukaryotes that is known to act within mitochon-
dria; mtDNA polymerase- (Pol). This holoenzyme consists of a
catalytic subunit encoded by PolgA and dimeric subunit encoded
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y Polg2 (reviewed in (Copeland and Longley, 2014)). The proof
eading activity of pol  can be reduced drastically by the substitu-
ion of critical residues, such as Asp198 and Glu200 (Longley et al.,
998), thus increasing the inherent error rate of pol. In wild type
ice it is this inherent error rate which is thought to be the major
ause of mutation accumulation in the mitochondrial genome dur-
ng ageing (Kennedy et al., 2013; Michikawa et al., 1999; Cortopassi
t al., 1992; Cortopassi and Arnheim, 1990). Thus, by reducing the
fﬁciency of the mitochondrial pol and thereby the accumulation
f mitochondrial mutations, the relationship between mitochon-
rial dysfunction and age-related phenotypes can be investigated
n these mice.
Inactivation of pol proof reading in mice by mutating the
ritical Asp257 resulted in several phenotypes related to ageing
eveloping in young mice in two separate studies (Trifunovic et al.,
004; Kujoth et al., 2005). Both sets of mutant mice (referred to
s PolG mice) exhibited kyphosis, alopecia, anemia, and weight
oss and there was a signiﬁcant reduction in median lifespan to
8 weeks (Trifunovic et al., 2004) and 59 weeks (Kujoth et al.,
005) in the separate studies. Further to this there was  reduced
at mass and reduced bone mineral density by 40 weeks and car-
iomyopathy in the PolG mice. Sarcopenia and hearing loss were
etected in the study by Kujoth et al. (Kujoth et al., 2005), both
ge-related phenotypes. Estimates of the increased rate of muta-
ion in different tissues from both strains were between 3 and 8
old higher than in wild type mice. There are slight variations in
he onset of these phenotypes between the two mutant strains
hich may  reﬂect the inﬂuence of background strain or environ-
ent but both lines display a similar accelerated development
f multiple phenotypes associated with ageing. PolG mice exhib-
ted the same levels of ROS damage and oxidative stress as wild
ype mice in tissue homogenates and MEFs from PolG mice did
ot exhibit accelerated cellular senescence in vitro (Kujoth et al.,
005). There was, however, evidence of increased levels of apopto-
is observed in the mutant mice (Kujoth et al., 2005). The reduced
ssembly of mitochondrial encoded components of the electron
ransport chain in muscle is thought to result in a reduced mito-
hondrial membrane potential and thus induces apoptosis (Hiona
t al., 2010). Thus, the causal link between the increased muta-
ion load and accelerated phenotypes in these mice is thought to
e a result of increased apoptosis. In more recent investigations
ssessing the mitochondrial fraction from PolG mice, rather than
hole tissue homogenates did detect increased ROS production
ver that observed in wild types (Safdar et al., 2016; Dai et al.,
010; Logan et al., 2014), suggesting ROS production may  indeed
lay a role in the development of the phenotypes observed in PolG
ice. Further to the phenotypes observed in the PolG mice, tis-
ue speciﬁc mutants of mtDNA pol also developed phenotypes
elevant to accelerated ageing (Kasahara et al., 2006; Zhang et al.,
000).
Mutant mice exhibit signiﬁcantly higher mutation loads in
itochondria from 2 months of age, thereby implying mutation
ccumulation is occurring during development. Despite bearing a
igniﬁcant mutation load at this age early onset ageing phenotypes
re not detectable. Conversely, the mutation rate does not increase
igniﬁcantly by 6 months of age when the accelerated ageing phe-
otypes are observed. This suggests that the phenotypes arise from
n accumulation of dysfunctional mitochondria, possibly by clonal
xpansion of mutant mitochondria (Trifunovic et al., 2004), result-
ng in increased levels of ROS/apoptosis and concomitant loss of
issue function.
Among the many beneﬁts endurance exercise brings (reviewed
n Mendonca et al. (2016)) is an increased mitochondrial biogene-
is (Holloszy and Booth, 1976). An exercise regimen extended the
ifespan of PolG mice signiﬁcantly (Safdar et al., 2011). In addition,
xercise had measurable beneﬁts on many of the early onset ageing Development 160 (2016) 41–53
phenotypes observed in sedentary PolG mice including preventing
sarcopoenia, anemia, cardiac hypertrophy and even increased the
levels of subcutaneous adipose tissue (Safdar et al., 2011). Not only
were there phenotypic beneﬁts, exercise reduced the frequency
of point mutations in PolG mice and reduced levels of apopto-
sis observed in tissues (Safdar et al., 2011). It is thought that ROS
induced p53 signaling in PolG mice increases cellular senescence
and inhibits mitogenesis and that this is reversed by exercise, thus
improving the health outcomes in PolG mice undergoing an exer-
cise regime (Safdar et al., 2016). Indeed it has been hypothesized
that exercise also induces the translocation of p53 to the mitochon-
dria where it acts to repair mutations (Safdar et al., 2016) thereby
preventing the cascade of events resulting in detrimental pheno-
types. Furthermore ROS levels do accumulate with age in PolG mice
which may  explain the delay in the development of phenotypes in
these mice despite the high mutational load in mitochondria in
young mice (Safdar et al., 2016).
Homozygous PolG mice have very high mutation rates which
may  result in the accelerated ageing phenotypes observed in these
mice. However, heterozygous KO mice, which exhibit no signs of
early ageing, also have a higher mutation rate than aged wild type
mice (Vermulst et al., 2007). This suggests that there is a thresh-
old for the accumulation under which there is little observable
effect on health during ageing. Indeed, these data also suggest
that the rate of accumulation of mitochondrial mutations during
normal ageing is not necessarily sufﬁcient to inﬂuence lifespan,
which has been supported in further studies (Guo et al., 2010). The
type of mutations in normal ageing may, however, be different to
that observed in PolG mice (Williams et al., 2010). Stem cell func-
tion is also affected in PolG mice but may  not recapitulate exactly
changes seen during ageing, with clear differences in changes in
gene expression between HSCs from PolG mice and those from age-
ing mice (Norddahl et al., 2011). Finally, whilst PolG mice exhibit
sarcopoenia they do not recapitulate all of the phenotypes observed
in normally aged muscle (Hiona et al., 2010).
In summary, PolG mice develop a greatly increased mutation
load in their mtDNA and develop many age-related phenotypes
early in life. However the link between mutation load and accel-
erated ageing, and indeed whether the observed phenotypes are
truly accelerated ageing, is not proven conclusively, even if pheno-
typically the PolG mice appear to age more rapidly. Of note, also
another mouse study conﬁrmed a causative link between mtDNA
mutations and ageing: homozygous knock-in mice that express a
proof-reading-deﬁcient version of PolgA (the nucleus-encoded cat-
alytic subunit of mtDNA polymerase; PolgAmut/PolgAmut) displayed
reduced lifespan and premature onset of ageing-related pheno-
types such as weight loss, reduced subcutaneous fat, alopecia,
kyphosis, osteoporosis, anemia, reduced fertility and heart enlarge-
ment (Trifunovic et al., 2004).
3.3. Inﬂammageing
Ageing is characterized by a chronic, low-grade inﬂamma-
tion, and this phenomenon has been termed as ‘inﬂammageing’
(Franceschi and Campisi, 2014). Consequently, interfering with
inﬂammatory signaling in mice resulted in several mouse models
with accelerated of delayed ageing phenotypes, e.g. brain-speciﬁc
IKK knockout mice, Nfkb1−/− mice and IL-10 deﬁcient mice (IL-
10tm/tm).
Nuclear factor kappa-light-chain-enhancer of activated B cells
(NF-B) is a protein complex that controls transcription of DNA,
cytokine production and cell survival and plays a key role in reg-
ulating the immune response. In an inactivated state, NF-B is
located in the cytosol complexed with the inhibitory protein IB.
The enzyme IB kinase (IKK) is able to phosphorylate IB, which
eventually results in IB degradation, followed by translocation
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f activated NF-B into the nucleus and subsequent transcriptional
ctivation. Interestingly, changes in NF-B activity severely affect
oth lifespan and health span of mice (Zhang et al., 2013b; Bernal
t al., 2014). Indeed, brain-speciﬁc IKK knockout mice showed
 pronounced phenotype of longevity, with median lifespan 23%
onger and maximal lifespan 20% longer than wild type mice. Strik-
ngly, this was also associated with cognitive improvement and
rotection against ageing-induced muscle and skin atrophy, bone
oss, and collagen cross-linking (Zhang et al., 2013b). So while
hey still age, these brain-speciﬁc IKK knockout appear to age
lower than normal mice (Zhang et al., 2013b). In contrast, loss
f Nfkb1 accelerated observable age-related characteristics lead-
ng to a decrease in lifespan: while all Nfkb1+/+ animals were still
live at 1 year, only 70% of Nfkb1−/− mice remained alive at this
ime (Bernal et al., 2014). Moreover, these mice showed premature
ge-related skeletal changes, increased tissue inﬂammation and
entral nervous system gliosis, reduced apoptosis and increased
ellular senescence (Bernal et al., 2014). Interestingly, accumula-
ion of telomere-dysfunctional senescent cells in Nfkb1−/− tissues
ould be blocked by anti-inﬂammatory or antioxidant treatment
f mice, highlighting the potential use of these mice to study age-
elated interventions (Jurk et al., 2014).
Interleukin-10 (IL-10) is a cytokine with anti-inﬂammatory
ctivities via amongst others suppression of macrophage activa-
ion and inhibition of the production of inﬂammatory cytokines
roduced by Th1 cells (Fiorentino et al., 1991a, 1991b). IL-10 deﬁ-
ient mice (IL-10tm/tm) were generated to understand the role of the
ytokine in immune regulation (Kuhn et al., 1993). These mice are
nemic and suffer from extensive enterocolitis, which was limited
n proximal colon under the speciﬁc pathogen-free (Kuhn et al.,
993). Inﬂammation in the colon was associated with deﬁcient
h1 cytokine production (Berg et al., 1996). The same study also
escribed that intensity of inﬂammation was dependent on the
ouse strain background. IL-10-deﬁcient mice are growth retarded
nd expressed increased lethality (Kuhn et al., 1993). Growth retar-
ation becomes evident between ages 3 and 4 weeks, at the age
–11 weeks around 75% of animals have 30% reduced body weight.
he growth retardation follows the course of anemia and devel-
pment of iron depletion. Lethality increases with age and 30% of
nimals are dead at the age of 3 months (Kuhn et al., 1993). In
-cell speciﬁc IL-10 mutants, the survival is affected only after the
mmune challenges (Roers et al., 2004). Namely, infection with Tox-
plasma gondii induced severe hepatitis with focal inﬂammatory
nﬁltrates and increased lethality (Roers et al., 2004). Interestingly,
-cell speciﬁc IL-10 mutants did not have increased mortality after
PS challenge, while full knockouts exhibited signiﬁcantly reduced
urvival (Roers et al., 2004). Additional studies with original IL-
0tm/tm mice have focused on the similarities with the human frailty
yndrome. IL-10tm/tm mice expressed signiﬁcantly faster muscle
trength decline with ageing (Walston et al., 2008). This physical
ecline was accompanied with the speciﬁc gene expression pro-
le and increased levels of IL-6, IL-1, TNF, IFN- and chemokine
igand 1 levels (Walston et al., 2008; Ko et al., 2012). Mortality and
GF-1 levels of IL-10tm/tm mice were signiﬁcantly elevated (Ko et al.,
012). IL-10tm/tm mice also have impaired cardiac functions com-
ared to the wild-type littermates (Sikka et al., 2013). One possible
ellular mechanism for these pathologies can be altered formation
f autophagosomes and increased levels of damaged mitochondria
n skeletal muscles of these mice (Ko et al., 2016). In summary, IL-
0tm/tm mice are a well-established model for frailty syndrome in
umans caused by increased inﬂammation..4. Other mouse models of accelerated ageing
Other mice with accelerated ageing phenotypes have also been
escribed, such as Klotho-deﬁcient mice and DNA repair mutant Development 160 (2016) 41–53 47
mice. These mice have been reviewed extensively (Vanhooren and
Libert, 2013; Liao and Kennedy, 2014). Interestingly, the absence
of Klotho in mice has strong effects on life expectancy (Kuro-o
et al., 1997), whereas overexpression of Klotho extends lifespan
(Kurosu et al., 2005) and functional variants of Klotho in humans are
associated either with longevity populations or with the onset and
severity of human age-related phenotypes (Arking et al., 2002). On
the other hand, mice with a mutation in XPD (xeroderma pigmen-
tosum, complementation group F), which encodes a DNA helicase
involved in both repair and transcription and is mutated in human
trichothiodystrophy, exhibit many symptoms of premature age-
ing, including osteoporosis, kyphosis, osteosclerosis, early graying,
cachexia, infertility, and reduced life-span (de Boer et al., 2002).
Similarly, genetically engineered mice with disabling mutations in
excision repair cross complementing gene (Ercc1; a protein that
forms a complex with XPF), have defects in DNA repair, accompa-
nied by metabolic stress-induced changes in physiology that result
in premature ageing (Weeda et al., 1997).
Patients with autosomal dominant dyskeratosis congenita are
now known to carry mutations in either the catalytic component
of telomerase (TERT) or in the gene that encodes its RNA template
(TERC). These patients have shortened telomeres and reduced lifes-
pan, and they show signs of accelerated ageing and bone marrow
failure with increased risk of life-threatening infections (Kirwan
and Dokal, 2009). Surprisingly, mice null for either Terc or Tert
seemed healthy and phenotypically unaffected, establishing that
telomerase activity is dispensable for life (Blasco et al., 1997; Farazi
et al., 2006). However, late-generation Terc−/− mice did show a
shortened lifespan, overall frailty, decreased fertility and tissue
atrophy with impaired organ function (Lee et al., 1998). Addition-
ally, Terc deﬁciency exacerbated the ageing phenotype of other
mutant mice (e.g. Wrn−/− mice as described above), which further
shows that multiple factors contribute to ageing and age-related
disorders (Sahin and Depinho, 2010).
It is important to note that also environmental factors such as
irradiation and stress inﬂuence the rate of ageing. Indeed, animal
experiments have shown that radiation exposure shortens lifespan.
However, this might have been due mainly to the development of
cancer (Richardson, 2009). Chronic psychological stress is believed
to inﬂuence the ageing process: in attempts to restore homeosta-
sis, the body activates several well-known mechanisms, including
the autonomic nervous system (ANS), the renin-angiotensin sys-
tem pathway, and the hypothalamic-pituitary-adrenal (HPA) axis
(Groeschel and Braam, 2011; Teixeira et al., 2015; Zhu et al., 2014).
As an example, exposing mice daily to rotational stress results in
skin ageing manifested in macroscopic changes and increased lev-
els of lipid peroxidation, carbonyl protein content, nitrotyrosine
levels, neutrophil inﬁltration, neutrophil elastase, tissue inhibitor
of metalloproteinase-1, and metalloproteinase-8 (Romana-Souza
and Santos Lima-Cezar, 2015). Additionally, chronic physiological
stress affects other organs, such as brain and muscles, and these
effects have been linked to silent mating type information regula-
tion 2 homolog (SIRT1) and to telomere length (Romana-Souza and
Santos Lima-Cezar, 2015; Prenderville et al., 2015; Ludlow et al.,
2012; McBurney et al., 2013).
3.5. Mouse models of delayed ageing
Mutant mice with extended lifespan are valuable for exploration
of the molecular basis of age-related pathophysiological changes of
age-related diseases. Several mutations causing dwarﬁsm in mice,
such as in Ames (Brown-Borg et al., 1996) and Snell dwarf mice
(Flurkey et al., 2001) (Table 2), have been reported to increase
lifespan.
Ames dwarf mice contain a recessive point mutation in Prop1
(homeobox protein prophet of pituitary transcription factor 1 (Pit1;
48 S. Kõks et al. / Mechanisms of Ageing and Development 160 (2016) 41–53
Table 2
Comparison of the two  dwarf mouse models.
Name Gene defect Affected organa Impact on lifespan Impact on physiologyb Relevant referencesc
Ames dwarf mice
(Prop1df/df)
Recessive point
mutation in the
Prop1 gene
Defects in pituitary
development
Low levels of GH, TSH
and PRL and
suppressive IGF levels.
49–68% increase in
mean lifespan
20–50% increase in
maximal lifespan
Reduced body size
Improved insulin
sensitive and glucose
tolerance
Enhanced memory and
learning skills
Downregulation of
PI3K/Akt/mTOR
pathway
(Brown-Borg et al.,
1996; Wu et al., 1998;
Li et al., 1990; Sharp
and Bartke, 2005;
Papaconstantinou and
Hsieh, 2015; Sanz et al.,
2002; Victoria et al.,
2015)
Snell  dwarf mice
(Pit1dw/dw)
Spontaneous
mutations in
the
Pit1 gene
Defects in the pituitary
development
Lack of GH, TSH and
PRL
40–50% increase in
mean and maximum
lifespan in females
Reduced body size
Diminished age-related
osteoarthritism and
splenanomegaly
Decelerated ageing of
immune system.
(Flurkey et al., 2001;
Silberberg, 1972)
(GH, growth hormone; IGF, insulin growth factor; mTOR, mechanistic target of rapamycin; PI3K, phosphatidylinositol 3-kinase; Pit1, pituitary transcription factor 1; PRL,
prolactin; Prop1, homeobox protein prophet of Pit1; TSH, thyroid-stimulating hormone).
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aa Affected organ due to the mutation.
b Observed physiological alterations.
c Relevant references listed.
ou1f1 (POU class 1 homeobox 1)). Inactivating mutations in Prop1
ead to defective differentiation of pituitary somatotrophic, thy-
otrophic and lactotrophic cells, which secrete growth hormone
GH), thyroid-stimulating hormone (TSH) and prolactin (PRL),
espectively (Wu et al., 1998; Li et al., 1990). The lifespans of
ale and female Ames dwarf mice are increased by 49% and 68%,
espectively, and maximal lifespan is lengthened by 20% and 50%
Brown-Borg et al., 1996). Based on the longevity of Ames dwarf
ice, several mechanisms that play a role in ageing have been
eported and ageing biomarkers have been described. The longevity
f Ames mice has been linked to GH signaling and translation con-
rol (Sharp and Bartke, 2005), to the level of phosphorylation of
peciﬁc insulin receptor substrate 1 (IRS-1) serines together with
he insulin/IGF-1 cross-talk (Papaconstantinou and Hsieh, 2015),
nd to milder oxidative damage to mitochondrial DNA, especially
n the brain (Sanz et al., 2002). Additionally, by analyzing cir-
ulating miRNAs in Ames dwarf mice and wild-type controls, a
genotype-by-age’ speciﬁc circulating miRNA signature was  identi-
ed (Victoria et al., 2015). This analysis also revealed functional
nrichment of miRNA targets related to different processes and
athways important in ageing, including tumor suppression, anti-
nﬂammatory response, modulation of Wnt, insulin signaling,
echanistic target of rapamycin (mTOR) and MAPK signaling path-
ays (Victoria et al., 2015).
Snell dwarf mice (Pit1dw/Pit1dw) have a spontaneous point
utation in the Pou1f1 gene (Pit1dw) that increases mean, median,
nd maximum lifespans by 40–50% in DW/J females (Flurkey
t al., 2002). However, contradictory results have been reported,
.g., shortening of median lifespan in Snell dwarf (Pit1dw/Pit1dw)
W/J males by about 25% (Flurkey and Harrison, 1990), which
as been explained by the contribution of environmental factors
o alteration of lifespan and probably to rates of ageing (Flurkey
t al., 2002). Interestingly, Snell dwarf mice show, in addition to
ncreased longevity, retardation of multiple indices of senescence,
ncluding diminished osteoarthritis (Silberberg, 1972), prevention
f age-dependent splenomegaly, impaired splenic T cell prolifer-
tion (Flurkey and Harrison, 1990) and decelerated changes in
ge-sensitive assays of connective tissue and immune system sta-
us (Flurkey et al., 2001). Like Ames mice, Snell mice have been
sed to identify key factors in the slowing of ageing. In the light of
his, proteostatic mechanisms, assessed by the ratio of new protein
o new DNA synthesis, were shown to be characteristic of slowed
geing independently of decrease mTORC1 (Drake et al., 2015).4. Intervention using caloric restriction
It is widely accepted that calorie restriction (CR) is one
of the most effective known methods for delaying the ageing
process and for supporting healthy ageing. In different mouse
models, CR reduces the risk factors for age-related chronic dis-
eases, such as cardiovascular diseases (CVD), diabetes, neuronal,
autoimmune, kidney, and respiratory diseases and cancer (Fontana
et al., 2010; Anderson and Weindruch, 2016; Trepanowski et al.,
2011; Speakman and Mitchell, 2011; Omodei and Fontana, 2011;
Taormina and Mirisola, 2014; Weindruch et al., 1986; Fontana and
Klein, 2007; Morley et al., 2010; Dogan et al., 2010). Different CR
protocols have been applied in mouse model studies on ageing (Van
Cauwenberghe et al., 2016). Many researchers restricted caloric
consumption by reducing the amount of total food or by reduc-
ing the amount of carbohydrates, fat, or protein in the diet. Others
used time-restricted feeding (tRF), whereby animals have access
to food for only four to eight hours a day but the total number of
calories consumed is not limited. In intermittent calorie restriction
(ICR) or intermittent fasting (IF), animals have access to food on
certain days during the week, as opposed to chronic calorie restric-
tion (CCR), in which food is restricted throughout the study. Most of
these studies reported beneﬁcial effects of different types of dietary
regimens on ageing or age-related diseases.
Mice are commonly used to study the effects of CR on ageing
and age-related diseases. They can be used to study the effect of
CR on lifespan or health-span because they are phylogenetically
close to humans and are more easily subjected to CR protocols
than invertebrates. Studies on mouse models have shown that
restricting caloric intake by 40–60% increases lifespan by 30–50%
and lowers the incidence of age-related loss of function and dis-
eases, including neurodegeneration (Fontana et al., 2010; Anderson
and Weindruch, 2016; Trepanowski et al., 2011; Speakman and
Mitchell, 2011; Omodei and Fontana, 2011; Taormina and Mirisola,
2014). Comparison of the disease proﬁles of Ames dwarf mice to
their normal siblings on a CR diet revealed that calorie restriction
and Ames dwarﬁsm exert their anti-ageing effects through a com-
mon  underlying mechanism, namely the change in the endocrine
system, especially in GH and IGF-1 levels (Ikeno et al., 2013). How-
ever, the pathological proﬁles of Ames dwarf and CR wild-type
mice also showed differences, suggesting that also unidentiﬁed
independent mechanisms extend lifespan and change age-related
pathology in these mice (Ikeno et al., 2013).
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2007) reported that different types of CR and IF protect neurons
against the negative effects of A and tau pathologies on synapticS. Kõks et al. / Mechanisms of Agei
.1. Effect of CR on lifespan is genotype-speciﬁc
Although it is widely accepted that CR is one of the most effective
ethods to attenuate ageing and age-related changes, recent stud-
es on mice have shown genotype-speciﬁc effects of CR in mouse
odels (Forster et al., 2003; Liao et al., 2010b; Rikke et al., 2010; Li
t al., 2012; Harper et al., 2006; Turturro et al., 1999). In this con-
ext, an early study reported that 40% CR extended the lifespan of
oth males and females of four different mouse strains or hybrid
1 mice (C57BL/6NNia, DBA/2Jnia, B6D2F1 and B6C3F1) (Turturro
t al., 1999). On the other hand, a recent study on 41 mouse strains
both male and female) reported that only 10 of 41 mouse strains
ad increased lifespan when mice were fed with 40% CR compared
o ad libitum (AL) feeding (Liao et al., 2010b). Remarkably, CR short-
ned the lifespan of most of the mouse strains (Liao et al., 2010b).
nother study in which male C57BL/6J and DBA/2 mice were fed
L from four months of age revealed no difference in their lifespan,
ut 40% CR extended the lifespan of C57BL/6J mice by 25% but did
ot affect the lifespan of DBA/2 mice (Forster et al., 2003). These
ndings are supported by a study by Dong-Li et al. (Li et al., 2012),
ho reported that different oxidative stress parameters in skeletal
uscle mitochondria increased with ageing in C57BL/6J but not in
BA/2 mice, and that this increase was attenuated by 40% CR (Li
t al., 2012). These studies show the genotype-speciﬁc effects of
R in mouse models. Therefore, it is important to choose mouse
odels appropriate for studying ageing and age-related diseases.
.2. The effects of CR on age-related cardiovascular diseases
CVD)
The prevalence of cardiomyopathies such as hypertension,
therosclerosis, myocardial ﬁbrosis and stroke increases with age-
ng (Omodei and Fontana, 2011; Lakatta and Levy, 2003; Donato
t al., 2013; Guo et al., 2002; Wielinga et al., 2011; McMillen et al.,
013). In recent years, CR varying from 30% to 60% has been pro-
osed as a powerful protective and therapeutic intervention for
ardiomyopathies of the ageing heart and vasculature. Long-term
R (up to 30 months) totally prevented the increase in arterial
ressure, pulse wave velocity (a measure of arterial stiffness),
rtery wall hypertrophy, myocardial ﬁbrosis, collagen content, left
entricular stiffness and endothelial dysfunction in large conduit
rteries, including the aorta and carotid artery, as well as in cere-
ral resistance arteries in B6D2F1 mice (Donato et al., 2013; Walker
t al., 2014; Weiss and Caloric, 2011; Yan et al., 2013). The authors
ttributed these improvements to preservation of aortic SIRT-1 pro-
ein expression, a mTOR signaling that regulates cellular nutrient
ensing in arteries and nitric oxide bioavailability, which sup-
resses vascular oxidative stress (Donato et al., 2013; Walker et al.,
014; Weiss and Caloric, 2011; Yan et al., 2013). In addition, when
ice aged 20 months were subjected to CR for two  months, the
igns of ageing cardiomyopathy were reversed (Yan et al., 2013;
ippe et al., 2010). This intervention was as effective as long-term
R started from an early age (Yan et al., 2013). Moreover, CR feeding
f old mice restored arterial antioxidant and SIRT-1 protein con-
entrations, indicating the amelioration of cardiomyopathies (Yan
t al., 2013, 2012; Rippe et al., 2010).
Many genetically modiﬁed mouse models have been used to
how the effects of CR on age-related molecules and on CVD. For
xample, homozygous apolipoprotein E gene (ApoE−/−) knock-
ut mice and low-density lipoprotein receptor (LDLR−/−) knockout
ice were used to show the beneﬁcial effects of CR againsttherosclerosis. When these mice were placed on different CR diets,
ncluding 60% CR, short term ICR and modiﬁcation of cholesterol
r fat intake, they developed smaller atherosclerotic lesions (Guo
t al., 2002; Wielinga et al., 2011; McMillen et al., 2013). Development 160 (2016) 41–53 49
4.3. The effects of CR on age-related metabolic diseases
Dietary effects on age-related metabolic disorders have been
shown in different mouse studies (Chaix et al., 2014; Hatori et al.,
2012). Mice fed different diets (including high fat diet (HFD), high
fructose diet restricted to eight hours a day and without reduc-
ing calorie intake) improved hepatic glucose metabolism, rhythms
of nutrient utilization and motor function, and increased bile acid
production (Chaix et al., 2014; Hatori et al., 2012). In addition,
tRF reduced gene expression levels of the inﬂammatory cytokines
IL-6, TNF and CXCL2 in white adipose tissue, serum cholesterol
levels and insulin resistance, and prevented liver damage and hep-
atosteatosis in C57BL/6J male mice (Chaix et al., 2014; Hatori et al.,
2012). Contrary to this, another tRF study (three hours of feeding
per day) on C57BL/6J male mice aged 11 weeks increased the levels
of inﬂammatory cytokines such as IL-6, TNF, NFkB and IL-1 as well
as the CRP serum level, which is a potential marker for increased
risk of coronary heart disease. In addition, circadian rhythm was
robust while mRNA expression of the anti-inﬂammatory cytokine
IL-10 was  decreased during tRF (Sherman et al., 2011). On the other
hand, tRF did not affect plasminogen activator inhibitor-1 (PAI-1), a
possible marker for thrombosis and susceptibility to heart attacks,
or arginase (Arg1), a marker for colorectal cancer and liver metas-
tases (Sherman et al., 2011).
4.4. The effects of CR on neurogenesis and age-related brain
diseases
CR has also been shown to affect age-related brain diseases such
as Alzheimer’s, Parkinson’s and Huntington’s diseases and stroke
(Van Cauwenberghe et al., 2016; Bondolﬁ et al., 2004; Patel et al.,
2005; Wang et al., 2005; Park et al., 2013; Wu  et al., 2008; Halagappa
et al., 2007; Hornsby et al., 2016; Duan et al., 2003; Mattson et al.,
2003). Using different mouse models, recent studies have reported
beneﬁcial effects of CR (including ICR and small meal size) on neu-
rogenesis, survival of neuronal cells, and restoration of neuronal
function following injury (Bondolﬁ et al., 2004; Patel et al., 2005;
Wang et al., 2005; Park et al., 2013; Wu  et al., 2008; Halagappa et al.,
2007; Hornsby et al., 2016; Duan et al., 2003; Mattson et al., 2003).
In addition, it was  reported that CR decreases the expression levels
of inﬂammation related genes in the hippocampus, and enhances
novel object recognition and contextual fear conditioning memory
in different mouse models (Bondolﬁ et al., 2004; Patel et al., 2005;
Park et al., 2013; Wu et al., 2008; Halagappa et al., 2007; Hornsby
et al., 2016; Mattson et al., 2003). In this context, Wu  et al. (Wu  et al.,
2008) have shown that CR improved novel object recognition and
contextual fear conditioning memory in the conditional double-
knockout mouse model for penicillin 1 and 2 (Wu et al., 2008).
Using DNA microarray analysis, they found decreased expression
of inﬂammation and increased expression of neurogenesis-related
genes in the hippocampus of calorie restricted conditional double-
knockout mice (Wu  et al., 2008). In another study, Park et al. (Park
et al., 2013) reported that CR increases the number of dividing
neuronal stem cells and progenitor cells in the dentate gyrus of
female Nestin-GFP mice. Based on their observations, they sug-
gested that CR increases the number of divisions that neural stem
cells and progenitor cells can undergo in the ageing brain of females
(Park et al., 2013). Moreover, Halagappa et al. (Halagappa et al.,function. They concluded that CR and IF dietary regimens can ame-
liorate age-related deﬁcits in cognitive functions (Halagappa et al.,
2007).
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. Summary
Although the mouse might not be an ideal model for studying
geing, its use as a model of mammalian biology will continue to
eliver important insights into the pathobiology of disease, funda-
ental processes involved in ageing, and the relationship between
geing and disease.
Here, we gave some examples of how mouse models of both
ccelerated and delayed ageing provide insight into the pathogenic
echanisms of the normal physiological ageing process and of pre-
ature ageing in progeroid syndromes. The ability of CR to delay
geing has been thoroughly validated in a broad range of mouse
odels of ageing. Further analysis of the underlying mechanisms
ight eventually lead to new therapies to postpone age-related
iseases. It should be kept in mind that inbred strains are limited
n genetic diversity and hence develop phenotypes speciﬁc to those
trains, but they are easy to manipulate genetically and extensive
aseline data are available. On the other hand, outbred mice are
ore representative of the genetic diversity of humans but they
resent problems in terms of altering the genome. While many lab-
ratories use similar techniques to study ageing, the development
f SOPs and standardized phenotyping, across a range of physi-
logical systems reﬂecting frailty as seen in patients, is urgently
equired. This will result in more consistent data on the speciﬁc
athways that are critical upon ageing and how pathway modula-
ion affects health.
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